{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:23:14Z","timestamp":1783117394039,"version":"3.54.6"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Pediatric moderate aplastic anemia (MAA) lacks defined diagnostic criteria and a clear standard of care due to limited understanding of its pathophysiology and natural history. To understand current diagnostic and management practices for pediatric patients with MAA, a survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC) was conducted among 104 providers across 57 institutions. The survey results show that the approach to MAA remains inconsistent. The survey demonstrates broad variability regarding the working definition, diagnostic work-up, and therapeutic management of children with MAA. The diagnostic work-up and treatment options for children with MAA are largely driven by management guidelines for pediatric severe aplastic anemia (SAA). Treatment triggers and preferred therapy types varied widely among respondents. Curated next-generation sequencing panels and whole exome\/whole genome sequencing were included by only 55% and 9% of respondents, respectively, suggesting the need to more broadly consider inherited bone marrow failure syndromes in the differential diagnosis of these patients. Based on the most commonly reported practices across NAPAAC institutions, we have included a proposed diagnostic and management algorithm in this manuscript. Effective, risk-adapted treatment for children with MAA requires a better understanding of the biology, natural history, and treatment outcomes in this heterogeneous population.<\/jats:p>","DOI":"10.1097\/mph.0000000000003209","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:01:32Z","timestamp":1779206492000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium"],"prefix":"10.1097","volume":"48","author":[{"given":"Linah","family":"Omer","sequence":"first","affiliation":[{"name":"University of Pennsylvania, Children\u2019s Hospital of Philadelphia, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Gloude","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, University of California San Diego, Rady Children\u2019s Hospital San Diego, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McGuinn","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, Weill Cornell Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo A.","family":"Nakano","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Overholt","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, Riley Hospital for Children, Indiana University, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ogando-Rivas","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Immune Deficiency, University of Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa A.","family":"Broglie","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, Pediatrics, Children\u2019s Wisconsin, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Hillier","sequence":"additional","affiliation":[{"name":"Hassenfeld Children\u2019s Hospital at NYU Langone Health and NYU Grossman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Stem Cell Transplant, Children and Adolescent Cancer and Blood Disease Center, Maria Fareri Children\u2019s Hospital, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Rothman","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasidhar","family":"Goteti","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Oncology, and BMT, University of Utah and Intermountain Health Primary Children's Hospital, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Dror","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, The Hospital for Sick Children, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda I.","family":"Cancio","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria P.","family":"Contreras Yametti","sequence":"additional","affiliation":[{"name":"Hassenfeld Children\u2019s Hospital at NYU Langone Health and NYU Grossman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Cada","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, The Hospital for Sick Children, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"Shimano","sequence":"additional","affiliation":[{"name":"Pediatric Allergy, Immunology, and Bone Marrow Transplant, Benioff Children\u2019s Hospitals, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Allen","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, UPMC Children\u2019s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Northwell Health, Cohen Children\u2019s Medical Center, Stem Cell Transplantation and Cellular Therapy, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kurre","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Children\u2019s Hospital of Philadelphia, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2813-1729","authenticated-orcid":false,"given":"Paul","family":"Castillo","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill L.O.","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Hematology-Oncology and Stem Cell Therapies, University of Chicago Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"R1-20260703","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jpeds.2008.06.004","article-title":"Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine","volume":"153","author":"Scheinberg","year":"2008","journal-title":"J Pediatr"},{"key":"R2-20260703","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjh.13297","article-title":"Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant","volume":"169","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"key":"R3-20260703","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ajh.26310","article-title":"Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium","volume":"96","author":"Shimano","year":"2021","journal-title":"Am J Hematol"},{"key":"R4-20260703","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bjh.16460","article-title":"Distinctive and common features of moderate aplastic anaemia","volume":"189","author":"Patel","year":"2020","journal-title":"Br J Haematol"},{"key":"R5-20260703","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12185-013-1263-6","article-title":"The progression risk factors of children with transfusion-independent non-severe aplastic anemia","volume":"97","author":"Wang","year":"2013","journal-title":"Int J Hematol"},{"key":"R6-20260703","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/pbc.20131","article-title":"Natural history of moderate aplastic anemia in children","volume":"43","author":"Howard","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20260703","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MPH.0b013e3182755f36","article-title":"Moderate aplastic anemia in children: preliminary outcomes for treatment versus observation from a single-institutional experience","volume":"35","author":"Brock","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-20260703","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12185-009-0302-9","article-title":"Natural history of transfusion-independent non-severe aplastic anemia in children","volume":"89","author":"Nishio","year":"2009","journal-title":"Int J Hematol"},{"key":"R9-20260703","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V45.3.355.355","article-title":"Selection of patients for bone marrow transplantation in severe aplastic anemia","volume":"45","author":"Camitta","year":"1975","journal-title":"Blood"},{"key":"R10-20260703","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/08880010902771549","article-title":"The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia","volume":"26","author":"Jiang","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"R11-20260703","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"key":"R12-20260703","doi-asserted-by":"crossref","first-page":"e14340","DOI":"10.1111\/petr.14340","article-title":"Efficacy of hematopoietic stem cell transplantation in the treatment of children with non-severe aplastic anemia","volume":"26","author":"Zhang","year":"2022","journal-title":"Pediatr Transplant"},{"key":"R13-20260703","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26305","article-title":"Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine","volume":"64","author":"Nishikawa","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20260703","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41375-023-02047-z","article-title":"Deciphering treatment patterns in non-severe\/moderate aplastic anemia: an international observational study","volume":"37","author":"Fattizzo","year":"2023","journal-title":"Leukemia"},{"key":"R15-20260703","first-page":"1370","article-title":"Long-term prognosis and residual abnormalities of idiopathic acquired aplastic anemia in children","volume":"52","author":"Tsukimoto","year":"1989","journal-title":"Nihon Ketsueki Gakkai Zasshi"},{"key":"R16-20260703","first-page":"80","article-title":"Outcome of moderate aplastic anemia in children","volume":"16","author":"Khatib","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R17-20260703","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood.V93.7.2191","article-title":"Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anemia Working Party","volume":"93","author":"Marsh","year":"1999","journal-title":"Blood"},{"key":"R18-20260703","first-page":"909","article-title":"Natural history of moderate aplastic anemia in children and effects of immunosuppressive therapy","volume":"46","author":"Qiao","year":"2008","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R19-20260703","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"key":"R20-20260703","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V106.11.1043.1043","article-title":"Prospective, randomized, multicenter study comparing antithymocyte globulin (ATG) alone with ATG Plus cyclosporine (CsA) for the treatment of children with nonsevere aplastic anemia (nSAA)","volume":"106","author":"Yagasaki","year":"2005","journal-title":"Blood Blood"},{"key":"R21-20260703","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/13696998.2019.1643354","article-title":"Healthcare costs and resource utilization in patients with severe aplastic anemia in the US","volume":"22","author":"Cai","year":"2019","journal-title":"J Med Econ"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:00:18Z","timestamp":1783116018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003209","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-10-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}